Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Lazarchick

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Annals of Clinical and Laboratory Science|August 22, 2008
Use of bivalirudin to prevent thrombosis following orthotopic liver transplantation in a patient with Budd-Chiari syndrome and a history of heparin-induced thrombocytopeniaBrent A Anderegg, G Mark Baillie, Walter E Uber, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 5, 2011
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomesWalter E Uber, John M Toole, Martha R Stroud, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 19, 2016
Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management studyGilles Pernod, Haifeng Wu, Emmanuel de Maistre, et al.
Experimental Hematology|September 30, 2009
Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemiaKeisuke Shirai, Yasuhiko Sera, William Bulkeley, et al.
Cancer Letters|October 13, 2018
Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascadeJing Zheng, Yonggang Sha, Logan Roof, et al.
Transfusion|August 8, 2017
Cases of transfusion-transmitted babesiosis occurring in nonendemic areas: a diagnostic dilemmaDavid P LeBel, Erin D Moritz, Jennifer J O'Brien, et al.
American Journal of Hematology|July 6, 2013
Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosisRussell W Jenkins, Christopher J Clarke, John Thomas Lucas, et al.
The Annals of Thoracic Surgery|April 30, 2008
Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgeryLyndsey J Bowman, Walter E Uber, Martha R Stroud, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 17, 2018
Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management studyCarlos Aguilar, Michelangelo Sartori, Armando D'Angelo, et al.
Thrombosis and Haemostasis|March 11, 2008
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situationsAndreas Tiede, R Campbell Tait, Don W Shaffer, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Annals of Clinical and Laboratory Science|August 22, 2008
Use of bivalirudin to prevent thrombosis following orthotopic liver transplantation in a patient with Budd-Chiari syndrome and a history of heparin-induced thrombocytopeniaBrent A Anderegg, G Mark Baillie, Walter E Uber, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 5, 2011
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomesWalter E Uber, John M Toole, Martha R Stroud, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 19, 2016
Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management studyGilles Pernod, Haifeng Wu, Emmanuel de Maistre, et al.
Experimental Hematology|September 30, 2009
Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemiaKeisuke Shirai, Yasuhiko Sera, William Bulkeley, et al.
Cancer Letters|October 13, 2018
Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascadeJing Zheng, Yonggang Sha, Logan Roof, et al.
Transfusion|August 8, 2017
Cases of transfusion-transmitted babesiosis occurring in nonendemic areas: a diagnostic dilemmaDavid P LeBel, Erin D Moritz, Jennifer J O'Brien, et al.
American Journal of Hematology|July 6, 2013
Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosisRussell W Jenkins, Christopher J Clarke, John Thomas Lucas, et al.
The Annals of Thoracic Surgery|April 30, 2008
Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgeryLyndsey J Bowman, Walter E Uber, Martha R Stroud, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 17, 2018
Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management studyCarlos Aguilar, Michelangelo Sartori, Armando D'Angelo, et al.
Thrombosis and Haemostasis|March 11, 2008
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situationsAndreas Tiede, R Campbell Tait, Don W Shaffer, et al.
Pageof 6